Vera Bril researcher
Bril, Vera.
VIAF ID: 315215807 (Personal)
Permalink: http://viaf.org/viaf/315215807
Preferred Forms
-
-
- 100 0 _ ‡a Vera Bril ‡c researcher
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Fcγ Receptor Polymorphisms Do Not Predict Response to Intravenous Immunoglobulin in Myasthenia Gravis | |
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse | |
Frequent laboratory abnormalities in CIDP patients | |
Gamunex® in Guillain-Barré Syndrome: A Postmarketing, Retrospective, Observational Study. | |
Gelsolin Familial Amyloidosis Peripheral Neuropathy in Canada: A Case Report | |
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar | |
Guidelines on the use of intravenous immune globulin for neurologic conditions | |
Home IVIG for CIDP: a focus on patient centred care. | |
How sensitive is the case definition for diabetic sensorimotor polyneuropathy to the use of different symptoms, signs, and nerve conduction parameters in type 1 diabetes? | |
Hyaline body myopathy: adulthood manifestations. | |
Image-Guided High Intensity Focused Ultrasound System for Large Animal Nerve Ablation Studies. | |
Impact of minimally invasive trans-cervical thymectomy on outcome in patients with myasthenia gravis | |
Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison | |
International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r | |
Intravenous immunoglobulin as treatment for myasthenia gravis: current evidence and outcomes | |
Ischaemia due to a vascular malformation causing focal myositis | |
IVIG treatment for myasthenia gravis: effectiveness, limitations, and novel therapeutic strategies | |
Laser Doppler Flare Imaging and Quantitative Thermal Thresholds Testing Performance in Small and Mixed Fiber Neuropathies | |
Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients with diabetic sensorimotor polyneuropathy | |
Muscle and nerve involvement in granulomatous mycosis fungoides | |
Muscle biopsy technical safety and quality using a self-contained, vacuum-assisted biopsy technique | |
Myasthenia Gravis Impairment Index: Responsiveness, meaningful change, and relative efficiency | |
Nerve function varies with hemoglobin A1c in controls and type 2 diabetes. | |
Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic | |
Neuromuscular complications of diabetes mellitus | |
New insights into very-late-onset myasthenia gravis | |
Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set. | |
Objective evidence for the reversibility of nerve injury in diabetic neuropathic cachexia | |
Performance of Different Criteria for Refractory Myasthenia Gravis | |
Peripheral nerve high-resolution ultrasound in diabetes | |
Peripheral Nerve Ultrasound Imaging Shows Enlargement of Peripheral Nerves Outside the Brachial Plexus in Neuralgic Amyotrophy | |
Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia. | |
Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study | |
Prospective study of stress, depression and personality in myasthenia gravis relapses | |
Psychometric Properties of the Quantitative Myasthenia Gravis Score and the Myasthenia Gravis Composite Scale | |
The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers. | |
Quantitative sonographic assessment of myotonia. | |
Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis. | |
Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocin-diabetic rats | |
Rapid Corneal Nerve Fiber Loss: A Marker of Diabetic Neuropathy Onset and Progression | |
Rare disease levels of evidence: Time for a new bar? | |
Recording Fewer Than 20 Potential Pairs With SFEMG May Suffice for the Diagnosis of Myasthenia Gravis. | |
Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes. | |
Repetitive nerve stimulation cutoff values for the diagnosis of myasthenia gravis | |
Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy | |
Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study | |
Rozpoznawanie i leczenie neuropatii cukrzycowej | |
Selective or predominant triceps muscle weakness in African-American patients with myasthenia gravis | |
The sensitivity and specificity of the neurological examination in polyneuropathy patients with clinical and electrophysiological correlations | |
Sex differences in neuropathic pain intensity in diabetes | |
Structure-function relationship between corneal nerves and conventional small-fiber tests in type 1 diabetes | |
Study protocol for a pilot, randomised, double-blinded, placebo controlled trial of perineural local anaesthetics and steroids for chronic post-traumatic neuropathic pain in the ankle and foot: the PREPLANS study | |
Subcutaneous immunoglobulin for treatment of multifocal motor neuropathy. | |
Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy | |
Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study | |
Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial | |
Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination | |
Ultrasound in Neuromuscular Disorders | |
Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study | |
Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy. | |
The utility of a single simple question in the evaluation of patients with myasthenia gravis | |
Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI | |
Validation of cooling detection threshold as a marker of sensorimotor polyneuropathy in type 2 diabetes | |
Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes. | |
Wytyczne dotyczące leczenia bolesnej neuropatii cukrzycowej opracowane na podstawie wiarygodnych i aktualnych danych naukowych : raport American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine oraz American Academy of Physical Medicine and Rehabilitation = Evidence-based guideline : treatment of painful diabetic neuropathy : report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation |